Is residual neuromuscular block following pancuronium a risk factor for postoperative pulmonary complications?
Berg
H
H
Odense Universitetshospital, Denmark.
D000005:Abdomen / Q000601:surgery; D000328:Adult; D000762:Anesthesia Recovery Period; D001279:Atracurium / Q000008:administration & dosage; D001842:Bone and Bones / Q000601:surgery; D017558:Elective Surgical Procedures; D005260:Female; D005544:Forecasting; D005836:Genitalia, Female / Q000601:surgery; D006801:Humans; D015994:Incidence; D008171:Lung Diseases / Q000209:etiology*; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D019148:Neuromuscular Blockade; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage* / Q000009:adverse effects; D010197:Pancuronium / Q000008:administration & dosage* / Q000009:adverse effects; D011183:Postoperative Complications; D011446:Prospective Studies; D012044:Regression Analysis; D012307:Risk Factors; D016037:Single-Blind Method; D013997:Time Factors; D014673:Vecuronium Bromide / Q000008:administration & dosage
D003473:Neuromuscular Nondepolarizing Agents; D001279:Atracurium; D014673:Vecuronium Bromide; D010197:Pancuronium